Search results for "FDA update"

Results 31 - 40 of about 100 for "FDA update".

Safety alert and advice on CT scanning in patients with insulin pumps | ACP Diabetes Monthly

The presence of an insulin pump should not preclude an appropriate and medically indicated CT scan, the FDA said.

CGM system approved for use without finger sticks | ACP Diabetes Monthly

A continuous glucose monitoring (CGM) system was approved and some infusion sets were recalled, the FDA recently announced.

Device approved to treat diabetic foot ulcers | ACP Diabetes Monthly

The shock-wave system is intended to be used with standard diabetic ulcer care in patients ages 22 years and older with ulcers lasting more than 30 days.

Rosiglitazone REMS ends, new insulin approved | ACP Diabetes Monthly

The FDA has determined that the Risk Evaluation and Mitigation Strategy is no longer necessary to ensure that the benefits of rosiglitazone-containing drugs outweigh their risks.

Warning on DPP-4 inhibitors and insulin recall | ACP Diabetes Monthly

Dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain that can be severe and disabling, and some insulin pods may fail, the FDA recently warned.

First AI device approved to detect diabetes-related eye problems | ACP Diabetes Monthly

The software analyzes images of the eye taken with a retinal camera and offers one of two results: “more than mild diabetic retinopathy detected: refer to an eye care professional” or “negative for more than mild diabetic retinopathy; rescreen

Continuous glucose monitoring system approved to direct therapy, but daily fingersticks still needed | ACP Diabetes Monthly

The G5 Mobile Continuous Glucose Monitoring System is now approved for patients and clinicians to use results directly from the device to make diabetes treatment decisions.

First continuous glucose monitoring system approved to be used with other devices | ACP Diabetes Monthly

The system is the first approved to be used with other diabetes devices, such as automated insulin-dosing systems, insulin pumps, or blood glucose meters, according to the FDA.

New drugs approved for diabetes | ACP Diabetes Monthly

The first generic version of pioglitazone hydrochloride (Actos) and a new indication for ranibizumab injection (Lucentis) were recently announced by the FDA.

Incretin mimetics' effects on pancreas under investigation | ACP Diabetes Monthly

The FDA is investigating reports of possible increased risk of pancreatitis and precancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes.

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next